home > news > detailed info

Digital Health and Wearables

Tomorrows Future Today

• Datwyler uses strategic partnerships to develop new solutions in the fields of wearables and digital health.
• The company’s health care offering is always designed towards improving the comfort of patients during treatment.
• The product portfolio and innovative healthcare solutions will be presented at several important trade fairs of the medical sector.

Digital health is a key focus for the healthcare industry at the moment. It has rightfully become one of the big trend topics and has a lot of potential for the future. Datwyler, the Swiss-based industrial supplier of state-of-the-art solutions for drug packaging and medical devices, is exploring the field of digital health since 2014. Strategic partnerships and cooperation with international innovative hubs, companies or Universities are key for Datwyler. “Our cooperation and partnerships create synergies and result in high-quality future-proof medical products — and therefore an improved offering for customers”, says Stefan Sevens, Vice President Medical Solutions at Datwyler. “Examples are the soft dry electrodes, an intelligent wound patch which was developed in the partnership with Coldplasmatech, or components for the wireless eye-tracking technology which are part of a cooperation with the Imec institute.”

Innovative solution for long-term EEG

At the beginning of the year, Datwyler presented its newest solution in the field of wearables: The innovative soft dry electrodes are based on a flexible conductive polymer and customizable design. The soft dry electrodes allow dry signal acquisition which eliminates the use of gels and decreases skin irritation significantly. The specific design and characteristics allow usage without special skin preparation and freedom of area for monitoring. „The soft dry electrodes are our solution for long-term EEG monitoring as they really improve the treatment comfort for patients”, says Stefan Sevens. During a long-term EEG, patients need to wear the electrodes over several days or even weeks. Datwyler’s electrodes offer high wearing comfort, are waterproof, flexible and biocompatible. „The higher comfort leads to a higher degree of relaxation, which in most therapies is of utmost importance“, amends Stefan Sevens.

Wireless eye-tracking technology

Datwyler has developed dry polymer electrodes for the glasses of a new wireless eye-tracking technology from Imec, a world-leading research and innovation hub in nano-electronics and digital health: Five dry-contact electrodes detect the eye-position. Together with a small battery they are laced in small boxes behind the wearer’s ear, making the glasses comfortable and wearable in daily life.

Intelligent wound patch

Together with Coldplasmatech, a start-up of the Leibniz Institute with focus on plasma research and technology, Datwyler developed a future-proof intelligent wound patch for the therapeutic treatment of chronic wounds. Via the complex technology of cold plasma, the intelligent wound patch eliminates germs and improves the wound healing through disinfection and cell activation. It is suitable for the therapeutic treatment of chronic wounds which are infected with multi-resistant germs. The patch can directly be applied to an open wound – only a few sessions are needed for recovery and each takes no longer than two minutes. The whole patch is thrice covered with liquid silicone in a complex injection molding process to ensure maximum safety.

Visitors can get a picture of Datwyler’s solutions and developments in the field of wearables and medical solutions at the most important industry events in that field. The trade fairs serve as good platforms where end users, health care professionals, suppliers, academics and other health care experts get together to exchange opinions, knowledge, information and more.

Datwyler will participate in the following events:

Neuroscience, San Diego, November 3 - 7, 2018, Booth 113

MEDICA, Düsseldorf, November 12 - 15, 2018, Booth 17C36

COMPAMED, Düsseldorf, November 12 - 15, 2018, Booth 8BD38

Wearable USA, Santa Clara, 14.-15. November, Booth O37


The Datwyler Group is an international supplier of state-of-the-art industrial components with leading positions in global and regional market segments. As technological leader, the Datwyler Group delivers added value to its customers in all markets served. Datwyler Sealing Solutions provides customized sealing solutions to manufacturers and companies which operate in the health care and automotive industry, as well as the market segments civil engineering and consumer goods. Within the health care division, Datwyler Sealing Solutions develops, designs and manufactures solutions for injectable packaging and drug delivery systems to facilitate customers to create a safer medical environment of tomorrow. The recently launched soft dry electrodes are paving the way to an unlimited pipeline of applications in a variety of industries. Looking back onto more than 100 years of history, Datwyler is a reliable partner, now and in the future!

For any inquiries, please contact:

Datwyler Sealing Solutions: Simone Ramser, Vice President Communications,, +41 41 875 1410
Print this page
Send to a friend
News and Press Releases

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

Industry Events

CPhI Korea

21-23 August 2019, COEX, Seoul, South Korea

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals. It also hosts an extensive conference programme covering the latest trends and topics within the regional market.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement